Software Healthcare Sector

Gain Therapeutics

Market Cap: US$87.5m

A biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.

Revium Rx

Market Cap: US$86.8m

Operates as a pre-clinical stage biopharmaceutical company focused on the development of nanoparticle-based therapies in the United States.

Ondine Biomedical

Market Cap: UK£63.6m

A life-sciences company, engages in the development of activated antimicrobial therapies for the prevention and treatment of infections in Canada and internationally.

Changming Industrial Management Group Holding

Market Cap: US$85.3m

Provides hospital management consultancy services to VIP maternity and gynecological centers in China.

Paradigm Biopharmaceuticals

Market Cap: AU$118.8m

Engages in the research and development of therapeutic products for human use in Australia.

Eloxx Pharmaceuticals

Market Cap: US$84.7m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia.

Dogwood Therapeutics

Market Cap: US$84.6m

A development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.

Eastwood Bio-Medical Canada

Market Cap: CA$117.1m

Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia.

MAIA Biotechnology

Market Cap: US$84.5m

A clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer.

Sera Prognostics

Market Cap: US$84.4m

A women’s health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States.

Rapid Micro Biosystems

Market Cap: US$84.3m

A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally.

Zomedica

Market Cap: US$84.2m

A veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals.

HLS Therapeutics

Market Cap: CA$116.0m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.

Verrica Pharmaceuticals

Market Cap: US$82.8m

A dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States.

ZeroStack

Market Cap: US$82.4m

Through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany.

OKYO Pharma

Market Cap: US$80.8m

A clinical-stage ophthalmology company, develops therapies for corneal and anterior diseases in the United Kingdom.

Cingulate

Market Cap: US$80.7m

A biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.

Elicio Therapeutics

Market Cap: US$79.9m

A clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer.

Recce Pharmaceuticals

Market Cap: AU$110.8m

Recce Pharmaceuticals Ltd, discovers, develops, and commercializes synthetic anti–infectives in Australia, the United Kingdom, and the United States.

Outset Medical

Market Cap: US$79.1m

A medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

Creo Medical Group

Market Cap: UK£57.8m

Through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom.

Citius Oncology

Market Cap: US$78.7m

Focuses on the development and commercialization of targeted oncology therapies.

Alterity Therapeutics

Market Cap: AU$109.8m

Engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson’s disease.

Telomir Pharmaceuticals

Market Cap: US$77.7m

A preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases.

Annovis Bio

Market Cap: US$77.5m

A clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States.

NeurAxis

Market Cap: US$77.2m

A medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.

Radius Residential Care

Market Cap: NZ$129.0m

Provides health and aged care services for elderly and disabled people in New Zealand.

Zentek

Market Cap: CA$105.1m

Engages in the research and development of graphene and related nanomaterials in Canada.

CVRx

Market Cap: US$75.7m

A commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.

Gossamer Bio

Market Cap: US$75.6m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States.

RetinalGenix Technologies

Market Cap: US$75.4m

RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders.

P3 Health Partners

Market Cap: US$74.9m

A patient-centered and physician-led population health management company, provides superior care services in the United States.

DarioHealth

Market Cap: US$73.4m

Operates as a digital health company in the United States and internationally.

OS Therapies

Market Cap: US$73.3m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

Kooth

Market Cap: UK£53.5m

Provides digital mental health services to children, young people, and adults in the United Kingdom.

Serina Therapeutics

Market Cap: US$72.9m

A biotechnology company, develops drugs to treat neurological diseases and pain.